- Home
- MDGL vs ACI Comparison
MDGL vs ACI Comparison
Compare MDGL & ACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- ACI
- Stock Information
- Founded
- MDGL 2011
- ACI 1860
- Country
- MDGL United States
- ACI United States
- Employees
- MDGL N/A
- ACI N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- ACI Food Chains
- Sector
- MDGL Health Care
- ACI Consumer Staples
- Exchange
- MDGL Nasdaq
- ACI Nasdaq
- Market Cap
- MDGL 9.6B
- ACI 9.8B
- IPO Year
- MDGL N/A
- ACI 2020
- Fundamental
- Price
- MDGL $423.00
- ACI $18.18
- Analyst Decision
- MDGL Strong Buy
- ACI Buy
- Analyst Count
- MDGL 12
- ACI 14
- Target Price
- MDGL $521.09
- ACI $24.21
- AVG Volume (30 Days)
- MDGL 277.8K
- ACI 8.9M
- Earning Date
- MDGL 11-04-2025
- ACI 10-14-2025
- Dividend Yield
- MDGL N/A
- ACI 3.28%
- EPS Growth
- MDGL N/A
- ACI N/A
- EPS
- MDGL N/A
- ACI 1.69
- Revenue
- MDGL $515,547,000.00
- ACI $81,370,600,000.00
- Revenue This Year
- MDGL $394.38
- ACI $4.86
- Revenue Next Year
- MDGL $64.73
- ACI $0.48
- P/E Ratio
- MDGL N/A
- ACI $10.79
- Revenue Growth
- MDGL 3421.98
- ACI 2.08
- 52 Week Low
- MDGL $213.71
- ACI $16.70
- 52 Week High
- MDGL $463.63
- ACI $23.20
- Technical
- Relative Strength Index (RSI)
- MDGL 46.03
- ACI 46.38
- Support Level
- MDGL $413.82
- ACI $18.36
- Resistance Level
- MDGL $436.79
- ACI $19.76
- Average True Range (ATR)
- MDGL 18.12
- ACI 0.53
- MACD
- MDGL -2.63
- ACI -0.01
- Stochastic Oscillator
- MDGL 48.76
- ACI 45.08
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About ACI Albertsons Companies Inc.
Albertsons is the second-largest supermarket operator in the United States with about 2,300 stores across a variety of banners. Around 80% of the firm's sales comes from nonperishable and fresh food, of which 26% comes from its portfolio of private brands. The company operates fuel centers at about 20% of its store locations and pharmacies at 75%. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of the outstanding shares.